Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study
2019
Keywords:
-
Correction
-
Cite
-
Save
0
References
0
Citations
NaN
KQI